The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on the topics that will be covered, including: CAR T cells, lipid nanoparticles and challenges encountered during the development of inhaled therapeutics.
Understanding the disposition of biotherapeutics is critical to assessing their pharmacologic and toxicologic behavior and can have substantial implications for drug development. Be sure to register for our pre-symposium workshop, Where Does My Protein Go and Why Does It Matter? The Role of PK/PD in Biotherapeutics, held on Sunday, September 10. Make sure to take this into consideration when finalizing your travel plans!
Don’t miss this opportunity to network with experts to gain valuable insight into the nonclinical development of your biotherapeutic.
If you register and reserve your hotel stay by Friday, August 11, you will receive the group rate.
For more information or to register today, visit our event webpage